A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study Meeting Abstract
| Authors: | Coleman, R. L.; Enserro, D.; Spirtos, N.; Herzog, T. J.; Sabbatini, P.; Armstrong, D. K.; Kim, B.; Fujiwara, K.; Walker, J. L.; Flynn, P. J.; Secord, A. A.; Cohn, D. E.; Brady, M. F.; Mannel, R. S. |
| Abstract Title: | A phase III randomized controlled trial of secondary surgical cytoreduction (SSC) followed by platinum-based combination chemotherapy (PBC), with or without bevacizumab (B) in platinum-sensitive, recurrent ovarian cancer (PSOC): A NRG Oncology/Gynecologic Oncology Group (GOG) study |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 294s |
| Language: | English |
| ACCESSION: | WOS:000442916002197 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.5501 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5501 -- Source: Wos |
